Stmnt re Press Comment
December 10 2001 - 4:53AM
UK Regulatory
RNS Number:4141O
Celsis International PLC
10 December 2001
Celsis International plc ("Celsis" or the "Company")
Following today's press speculation concerning the appointment of advisers to
sell the Company, the Board of Celsis confirms that it has decided to pursue a
review of strategic options, including a possible sale of the Company or a
division, and that PwC Corporate Finance and WestLB Panmure are assisting the
Company in carrying out this review. This review is at a very early stage.
A further announcement will be made in due course.
10 December 2001
Celsis International Plc 01223 426 008
Jay LeCoque
Peter Grant
PwC Corporate Finance 020 7583 5000
Neal Ransome
Mark Butler
WestLB Panmure 020 7020 4000
Ron Oppenshaw
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024